MITO END-3: A Randomized Phase II Trial of Avelumab Plus Carboplatin and Paclitaxel Compared to Carboplatin and Paclitaxel in Advanced or Recurrent Endometrial Cancer

SSRN Electronic Journal(2022)

引用 0|浏览3
暂无评分
关键词
endometrial cancer,paclitaxel,avelumab,carboplatin
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要